Companies / MRNA vs TECH
MRNA vs TECH: Moderna and Bio-Techne
Moderna (MRNA) reported $1.9B in revenue against a -145.2% net margin, while Bio-Techne (TECH) reported $1.2B at a 15.0% net margin, most recently.
| Metric | MRNA | TECH |
|---|---|---|
| Revenue | $1.9B | $1.2B |
| Net Income | $-2.8B | $0.2B |
| Gross Margin | 55.3% | 65.8% |
| Operating Margin | -158.1% | 20.7% |
| EPS (Diluted) | $-7.26 | $1.16 |
| Free Cash Flow | $-2.1B | $0.3B |
| Total Debt | $0.6B | $0.2B |
| P/E Ratio | n/m | 60.9× |
| P/B Ratio | 1.3× | 5.2× |
| Stock Price | $241.26 | $72.66 |
Free: last 5 years
| Fiscal year | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| MRNA Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | $18.5B | $19.3B | $6.8B | $3.2B | $1.9B |
| TECH Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | — | $1.1B | $1.1B | $1.2B | $1.2B |